Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Next-generation sequencing technology for medicine and research in Mainz

09.06.2010
Mainz’s Center for Translational Oncology and Immunology (TrOn) has received one of the world's first Illumina HiSeq genome sequencers

A next generation genome sequencer has been received in the newly launched Center for Translational Oncology Mainz and Immunology (TrOn) in Mainz. With the Illumina HiSeq 2000 instrument, the genetic material of cells can be completely decoded within a few days.

"The performance of TrOn as an innovation center and hub of the CI3 regional network of science and business is strengthened by this technology. This is therefore another important step to make Mainz a globally competitive center for personalized medicine," says Univ.-Prof. Dr. Ugur Sahin, director of TrOn. “The new technology allows us to examine the genetic information in tumor and immune cells quickly and inexpensively in order to gain a better understanding of the interplay of cancer treatment and immune system. This is necessary to develop customized therapies for individual patients."

"The new instrument is eight times more powerful than previous methods," says Dr. John Castle, head of Bioinformatics/Genomics at TrOn. "This represents not only a significant reduction of time and costs, but also more information that must be analyzed. For this, we are well positioned by our cooperation with the University of Mainz Center for High Performance Computing (ZDV)."

Understanding the characteristics of individual cancer patients is the basis for a customized treatment and thus critical to a successful therapy. "Individualized" and targeted medicine offers a great promise to significantly improve cancer therapy, both decreasing the cost of health care and improving patient lives. The dramatically increased ability to decode genomes ushered in by this next era of DNA sequencing makes the vision possible.

University President Univ.-Prof. Dr. Georg Krausch, a member of the successful Mainz "City of Science 2011" team, commented: "This is one of the puzzle pieces which we want at our site: cutting-edge research to resolve major social challenges."

Press contact
Christine Castle
CIMT Communications
TrOn - Translationale Onkologie gGmbH
Phone: +49 (0) 6131/17-8025
E-Mail: christine.castle@tron-mainz.de
Internet: http://www.tron-mainz.de
About the Center for Translational Oncology and Immunology (TrOn)
The Center for Translational Oncology and Immunology (TrOn) was founded in February 2010. Its partners include the state of Rhineland-Palatinate, the Johannes Gutenberg-University Mainz and the University Medical Center Mainz. The mission of the TrOn, under the direction of Univ.-Prof. Dr. Ugur Sahin, is to advance medical and scientific discoveries from research to patient treatment.
About the CI3-cluster
The cluster for Individualized Immune Intervention (CI3) is a regional network of science and industry, including three universities, six colleges, two Max Planck Institutes, the Paul-Ehrlich-Institute, the Association for Cancer Immunotherapy (CIMT), the European Business School, the Center for Translational Immunology and Oncology (TrOn), four large pharmaceutical companies and more than 180 small and medium-sized companies from biotechnology and health care. The network focuses on immunotherapy, the fastest growing pharmaceutical market segment, with the mission to turn the Rhine-Main region into a European immunotherapy center.

Caroline Bahnemann | idw
Further information:
http://www.tron-mainz.de
http://www.unimedizin-mainz.de/

More articles from Health and Medicine:

nachricht Satellites, airport visibility readings shed light on troops' exposure to air pollution
09.12.2016 | Veterans Affairs Research Communications

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>